Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001325812-10-000045
Filing Date
2010-12-10
Accepted
2010-12-10 17:06:30
Documents
1
Period of Report
2010-12-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4951
  Complete submission text file 0001325812-10-000045.txt   6790
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Greene Barry E (Reporting) CIK: 0001291963 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50743 | Film No.: 101245708